Sivaskandarajah et al. used an inducible Cre-loxP gene-targeting system that enabled genetic deletion of VEGF-A selectively from glomerular podocytes of wild type mice, and then type 1 diabetes was induced in mice using streptozotocin (STZ). This evidence concerns the gene VEGFA and type 1 diabetes mellitus.